Physician profile

James Noto

Neurology (Psychiatry & Neurology) · Plains, PA

NPI 1245641430

$4,399.34

in general payments reported to CMS, 2019-2025

38 companies · $225 in 2025

The $225 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,246.61
Education$125.37

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $1,380.11 2021-2025
Teva Pharmaceuticals USA, INC. $359.01 2019-2023 Ajovy
Alexion Pharmaceuticals, INC. $325.62 2019-2023 Ultomiris, Soliris
Amgen INC. $301.57 2020-2022
Eisai INC. $204.07 2019-2022
Biogen, INC. $196.15 2021-2023 Vumerity, Plegridy, Tysabri
Novartis Pharmaceuticals Corporation $186.15 2021-2024
Biohaven Pharmaceuticals, INC. $139.41 2021
Acadia Pharmaceuticals INC $117.08 2019-2023 Nuplazid
Csl Behring $111.59 2022-2023 Hizentra
Avion Pharmaceuticals $103.78 2022
Amneal Pharmaceuticals LLC $102.11 2021-2022
Lilly USA, LLC $87.32 2019-2022
Allergan, INC. $82.88 2020-2022
Genzyme Corporation $77.01 2021-2022
Show all 38 companies
CompanyGeneral paymentsYearsTop products
Kyowa Kirin, INC. $57.62 2021-2022
Lundbeck LLC $50.11 2021-2022
Novo Nordisk INC $44.22 2019
Sk Life Science, INC. $39.31 2021
Neurocrine Biosciences, INC. $36.44 2022
Janssen Pharmaceuticals, INC $34.44 2022
Biohaven Pharmaceutical Holding Company LTD. $33.96 2022
Pfizer INC. $33.29 2023-2024
Supernus Pharmaceuticals, INC. $31.88 2021
Livanova USA, INC. $30.44 2023 Vns Therapy Sentiva Model 1000 Generator
Ge Healthcare $29.92 2022
Argenx US, INC. $27.88 2023 Vyvgart
Sunovion Pharmaceuticals INC. $26.03 2022
Greenwich Biosciences, INC. $21.23 2021
Mdd US Operations, LLC $20.83 2021
Neurelis, INC. $18.42 2021
Alnylam Pharmaceuticals INC. $15.86 2024 Givlaari
Otsuka America Pharmaceutical, INC. $14.14 2023 Nuedexta
Catalyst Pharmaceuticals, INC. $12.71 2021
Impel Pharmaceuticals INC. $12.16 2022
Aprecia Pharmaceuticals, LLC $12.00 2021
Braemar Manufacturing, LLC $11.46 2019
Tanabe Pharma America, INC. $11.13 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

James Noto

$4,399.34

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbvie INC.
Context
The $225 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).

https://glasscript.com/doctor/5698948/james-noto

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.